Return to homepagePandemic Pact

Obtaining Remdesivir derivatives as new potential inhibitors of the main protease (Mpro) of SARS-CoV-2: from planning to pre-clinical trial

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2022

  • Known Financial Commitments (USD)

    $24,200

  • Funder

    FAPES Brazil

  • Principal Investigator

    Heberth de Paula

  • Research Location

    Brazil

  • Lead Research Institution

    UFES - ALEGRE

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract